 | • レポートコード：GIR-107A01442 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アルファアドレナリン受容体拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルファアドレナリン受容体拮抗薬の種類別市場規模（経口、注射）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルファアドレナリン受容体拮抗薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Pfizer、Pro Doc、Concordia Pharmaceuticals、Covis Pharmaceuticals、Aspri Pharma、Roerig、Greenstone、Boehringer Ingelheim、Cardinal Health、Teva、Glaxosmithkline、Actavis、Merck、Jubilant Generics、Astellas Pharma、Allergan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射 ・用途別分析2016年-2026年：病院、診療所 ・アルファアドレナリン受容体拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルファアドレナリン受容体拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルファアドレナリン受容体拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルファアドレナリン受容体拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルファアドレナリン受容体拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alpha-Adrenoreceptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alpha-Adrenoreceptor Antagonists size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Alpha-Adrenoreceptor Antagonists market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alpha-Adrenoreceptor Antagonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Alpha-Adrenoreceptor Antagonists market are listed below:
Sanofi
Pfizer
Pro Doc
Concordia Pharmaceuticals
Covis Pharmaceuticals
Aspri Pharma
Roerig
Greenstone
Boehringer Ingelheim
Cardinal Health
Teva
Glaxosmithkline
Actavis
Merck
Jubilant Generics
Astellas Pharma
Allergan
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Alpha-Adrenoreceptor Antagonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha-Adrenoreceptor Antagonists, with price, sales, revenue and global market share of Alpha-Adrenoreceptor Antagonists from 2019 to 2021.
Chapter 3, the Alpha-Adrenoreceptor Antagonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha-Adrenoreceptor Antagonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Alpha-Adrenoreceptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Alpha-Adrenoreceptor Antagonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Alpha-Adrenoreceptor Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alpha-Adrenoreceptor Antagonists Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Alpha-Adrenoreceptor Antagonists Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Alpha-Adrenoreceptor Antagonists Market Size & Forecast
1.4.1 Global Alpha-Adrenoreceptor Antagonists Sales in Value (2016-2026))
1.4.2 Global Alpha-Adrenoreceptor Antagonists Sales in Volume (2016-2026)
1.4.3 Global Alpha-Adrenoreceptor Antagonists Price by Type (2016-2026) & (US$/Ton)
1.5 Global Alpha-Adrenoreceptor Antagonists Production Capacity Analysis
1.5.1 Global Alpha-Adrenoreceptor Antagonists Total Production Capacity (2016-2026)
1.5.2 Global Alpha-Adrenoreceptor Antagonists Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha-Adrenoreceptor Antagonists Market Drivers
1.6.2 Alpha-Adrenoreceptor Antagonists Market Restraints
1.6.3 Alpha-Adrenoreceptor Antagonists Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Alpha-Adrenoreceptor Antagonists Product and Services
2.1.4 Sanofi Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Alpha-Adrenoreceptor Antagonists Product and Services
2.2.4 Pfizer Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pro Doc
2.3.1 Pro Doc Details
2.3.2 Pro Doc Major Business
2.3.3 Pro Doc Alpha-Adrenoreceptor Antagonists Product and Services
2.3.4 Pro Doc Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Concordia Pharmaceuticals
2.4.1 Concordia Pharmaceuticals Details
2.4.2 Concordia Pharmaceuticals Major Business
2.4.3 Concordia Pharmaceuticals Alpha-Adrenoreceptor Antagonists Product and Services
2.4.4 Concordia Pharmaceuticals Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Covis Pharmaceuticals
2.5.1 Covis Pharmaceuticals Details
2.5.2 Covis Pharmaceuticals Major Business
2.5.3 Covis Pharmaceuticals Alpha-Adrenoreceptor Antagonists Product and Services
2.5.4 Covis Pharmaceuticals Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Aspri Pharma
2.6.1 Aspri Pharma Details
2.6.2 Aspri Pharma Major Business
2.6.3 Aspri Pharma Alpha-Adrenoreceptor Antagonists Product and Services
2.6.4 Aspri Pharma Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Roerig
2.7.1 Roerig Details
2.7.2 Roerig Major Business
2.7.3 Roerig Alpha-Adrenoreceptor Antagonists Product and Services
2.7.4 Roerig Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Greenstone
2.8.1 Greenstone Details
2.8.2 Greenstone Major Business
2.8.3 Greenstone Alpha-Adrenoreceptor Antagonists Product and Services
2.8.4 Greenstone Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Alpha-Adrenoreceptor Antagonists Product and Services
2.9.4 Boehringer Ingelheim Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Cardinal Health
2.10.1 Cardinal Health Details
2.10.2 Cardinal Health Major Business
2.10.3 Cardinal Health Alpha-Adrenoreceptor Antagonists Product and Services
2.10.4 Cardinal Health Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Teva
2.11.1 Teva Details
2.11.2 Teva Major Business
2.11.3 Teva Alpha-Adrenoreceptor Antagonists Product and Services
2.11.4 Teva Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Glaxosmithkline
2.12.1 Glaxosmithkline Details
2.12.2 Glaxosmithkline Major Business
2.12.3 Glaxosmithkline Alpha-Adrenoreceptor Antagonists Product and Services
2.12.4 Glaxosmithkline Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Actavis
2.13.1 Actavis Details
2.13.2 Actavis Major Business
2.13.3 Actavis Alpha-Adrenoreceptor Antagonists Product and Services
2.13.4 Actavis Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Merck
2.14.1 Merck Details
2.14.2 Merck Major Business
2.14.3 Merck Alpha-Adrenoreceptor Antagonists Product and Services
2.14.4 Merck Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Jubilant Generics
2.15.1 Jubilant Generics Details
2.15.2 Jubilant Generics Major Business
2.15.3 Jubilant Generics Alpha-Adrenoreceptor Antagonists Product and Services
2.15.4 Jubilant Generics Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Astellas Pharma
2.16.1 Astellas Pharma Details
2.16.2 Astellas Pharma Major Business
2.16.3 Astellas Pharma Alpha-Adrenoreceptor Antagonists Product and Services
2.16.4 Astellas Pharma Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Allergan
2.17.1 Allergan Details
2.17.2 Allergan Major Business
2.17.3 Allergan Alpha-Adrenoreceptor Antagonists Product and Services
2.17.4 Allergan Alpha-Adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Alpha-Adrenoreceptor Antagonists Sales by Manufacturer
3.1 Global Alpha-Adrenoreceptor Antagonists Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Alpha-Adrenoreceptor Antagonists Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Alpha-Adrenoreceptor Antagonists
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha-Adrenoreceptor Antagonists Manufacturer Market Share
3.4.2 Top 6 Alpha-Adrenoreceptor Antagonists Manufacturer Market Share
3.5 Global Alpha-Adrenoreceptor Antagonists Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Alpha-Adrenoreceptor Antagonists Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alpha-Adrenoreceptor Antagonists Market Size by Region
4.1.1 Global Alpha-Adrenoreceptor Antagonists Sales in Volume by Region (2016-2026)
4.1.2 Global Alpha-Adrenoreceptor Antagonists Revenue by Region (2016-2026)
4.2 North America Alpha-Adrenoreceptor Antagonists Revenue (2016-2026)
4.3 Europe Alpha-Adrenoreceptor Antagonists Revenue (2016-2026)
4.4 Asia-Pacific Alpha-Adrenoreceptor Antagonists Revenue (2016-2026)
4.5 South America Alpha-Adrenoreceptor Antagonists Revenue (2016-2026)
4.6 Middle East and Africa Alpha-Adrenoreceptor Antagonists Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Alpha-Adrenoreceptor Antagonists Sales in Volume by Type (2016-2026)
5.2 Global Alpha-Adrenoreceptor Antagonists Revenue by Type (2016-2026)
5.3 Global Alpha-Adrenoreceptor Antagonists Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Alpha-Adrenoreceptor Antagonists Sales in Volume by Application (2016-2026)
6.2 Global Alpha-Adrenoreceptor Antagonists Revenue by Application (2016-2026)
6.3 Global Alpha-Adrenoreceptor Antagonists Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2026)
7.2 North America Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2026)
7.3 North America Alpha-Adrenoreceptor Antagonists Market Size by Country
7.3.1 North America Alpha-Adrenoreceptor Antagonists Sales in Volume by Country (2016-2026)
7.3.2 North America Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2026)
8.2 Europe Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2026)
8.3 Europe Alpha-Adrenoreceptor Antagonists Market Size by Country
8.3.1 Europe Alpha-Adrenoreceptor Antagonists Sales in Volume by Country (2016-2026)
8.3.2 Europe Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2026)
9.2 Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2026)
9.3 Asia-Pacific Alpha-Adrenoreceptor Antagonists Market Size by Region
9.3.1 Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Alpha-Adrenoreceptor Antagonists Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2026)
10.2 South America Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2026)
10.3 South America Alpha-Adrenoreceptor Antagonists Market Size by Country
10.3.1 South America Alpha-Adrenoreceptor Antagonists Sales in Volume by Country (2016-2026)
10.3.2 South America Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2026)
11.2 Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2026)
11.3 Middle East & Africa Alpha-Adrenoreceptor Antagonists Market Size by Country
11.3.1 Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Alpha-Adrenoreceptor Antagonists Typical Distributors
12.3 Alpha-Adrenoreceptor Antagonists Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Alpha-Adrenoreceptor Antagonists Revenue by Type, (USD Million), 2021-2026
Table 2. Global Alpha-Adrenoreceptor Antagonists Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Alpha-Adrenoreceptor Antagonists Product and Services
Table 6. Sanofi Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Alpha-Adrenoreceptor Antagonists Product and Services
Table 10. Pfizer Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pro Doc Basic Information, Manufacturing Base and Competitors
Table 12. Pro Doc Major Business
Table 13. Pro Doc Alpha-Adrenoreceptor Antagonists Product and Services
Table 14. Pro Doc Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Concordia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Concordia Pharmaceuticals Major Business
Table 17. Concordia Pharmaceuticals Alpha-Adrenoreceptor Antagonists Product and Services
Table 18. Concordia Pharmaceuticals Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Covis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Covis Pharmaceuticals Major Business
Table 21. Covis Pharmaceuticals Alpha-Adrenoreceptor Antagonists Product and Services
Table 22. Covis Pharmaceuticals Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Aspri Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Aspri Pharma Major Business
Table 25. Aspri Pharma Alpha-Adrenoreceptor Antagonists Product and Services
Table 26. Aspri Pharma Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Roerig Basic Information, Manufacturing Base and Competitors
Table 28. Roerig Major Business
Table 29. Roerig Alpha-Adrenoreceptor Antagonists Product and Services
Table 30. Roerig Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Greenstone Basic Information, Manufacturing Base and Competitors
Table 32. Greenstone Major Business
Table 33. Greenstone Alpha-Adrenoreceptor Antagonists Product and Services
Table 34. Greenstone Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 36. Boehringer Ingelheim Major Business
Table 37. Boehringer Ingelheim Alpha-Adrenoreceptor Antagonists Product and Services
Table 38. Boehringer Ingelheim Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 40. Cardinal Health Major Business
Table 41. Cardinal Health Alpha-Adrenoreceptor Antagonists Product and Services
Table 42. Cardinal Health Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Teva Basic Information, Manufacturing Base and Competitors
Table 44. Teva Major Business
Table 45. Teva Alpha-Adrenoreceptor Antagonists Product and Services
Table 46. Teva Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 48. Glaxosmithkline Major Business
Table 49. Glaxosmithkline Alpha-Adrenoreceptor Antagonists Product and Services
Table 50. Glaxosmithkline Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Actavis Basic Information, Manufacturing Base and Competitors
Table 52. Actavis Major Business
Table 53. Actavis Alpha-Adrenoreceptor Antagonists Product and Services
Table 54. Actavis Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Merck Basic Information, Manufacturing Base and Competitors
Table 56. Merck Major Business
Table 57. Merck Alpha-Adrenoreceptor Antagonists Product and Services
Table 58. Merck Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 60. Jubilant Generics Major Business
Table 61. Jubilant Generics Alpha-Adrenoreceptor Antagonists Product and Services
Table 62. Jubilant Generics Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Astellas Pharma Major Business
Table 65. Astellas Pharma Alpha-Adrenoreceptor Antagonists Product and Services
Table 66. Astellas Pharma Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Allergan Basic Information, Manufacturing Base and Competitors
Table 68. Allergan Major Business
Table 69. Allergan Alpha-Adrenoreceptor Antagonists Product and Services
Table 70. Allergan Alpha-Adrenoreceptor Antagonists Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Alpha-Adrenoreceptor Antagonists Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 72. Global Alpha-Adrenoreceptor Antagonists Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Alpha-Adrenoreceptor Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Alpha-Adrenoreceptor Antagonists Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 75. Head Office and Alpha-Adrenoreceptor Antagonists Production Site of Key Manufacturer
Table 76. Alpha-Adrenoreceptor Antagonists New Entrant and Capacity Expansion Plans
Table 77. Alpha-Adrenoreceptor Antagonists Mergers & Acquisitions in the Past Five Years
Table 78. Global Alpha-Adrenoreceptor Antagonists Sales by Region (2016-2021e) & (Kiloton)
Table 79. Global Alpha-Adrenoreceptor Antagonists Sales by Region (2021-2026) & (Kiloton)
Table 80. Global Alpha-Adrenoreceptor Antagonists Revenue by Region (2016-2021e) & (USD Million)
Table 81. Global Alpha-Adrenoreceptor Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 82. Global Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2021e) & (Kiloton)
Table 83. Global Alpha-Adrenoreceptor Antagonists Sales by Type (2021-2026) & (Kiloton)
Table 84. Global Alpha-Adrenoreceptor Antagonists Revenue by Type (2016-2021e) & (USD Million)
Table 85. Global Alpha-Adrenoreceptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 86. Global Alpha-Adrenoreceptor Antagonists Price by Type (2016-2021e) & (US$/Ton)
Table 87. Global Alpha-Adrenoreceptor Antagonists Price by Type (2021-2026) & (US$/Ton)
Table 88. Global Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2021e) & (Kiloton)
Table 89. Global Alpha-Adrenoreceptor Antagonists Sales by Application (2021-2026) & (Kiloton)
Table 90. Global Alpha-Adrenoreceptor Antagonists Revenue by Application (2016-2021e) & (USD Million)
Table 91. Global Alpha-Adrenoreceptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 92. Global Alpha-Adrenoreceptor Antagonists Price by Application (2016-2021e) & (US$/Ton)
Table 93. Global Alpha-Adrenoreceptor Antagonists Price by Application (2021-2026) & (US$/Ton)
Table 94. North America Alpha-Adrenoreceptor Antagonists Sales by Country (2016-2021e) & (Kiloton)
Table 95. North America Alpha-Adrenoreceptor Antagonists Sales by Country (2021-2026) & (Kiloton)
Table 96. North America Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 97. North America Alpha-Adrenoreceptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 98. North America Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2021e) & (Kiloton)
Table 99. North America Alpha-Adrenoreceptor Antagonists Sales by Type (2021-2026) & (Kiloton)
Table 100. North America Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2021e) & (Kiloton)
Table 101. North America Alpha-Adrenoreceptor Antagonists Sales by Application (2021-2026) & (Kiloton)
Table 102. Europe Alpha-Adrenoreceptor Antagonists Sales by Country (2016-2021e) & (Kiloton)
Table 103. Europe Alpha-Adrenoreceptor Antagonists Sales by Country (2021-2026) & (Kiloton)
Table 104. Europe Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 105. Europe Alpha-Adrenoreceptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 106. Europe Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2021e) & (Kiloton)
Table 107. Europe Alpha-Adrenoreceptor Antagonists Sales by Type (2021-2026) & (Kiloton)
Table 108. Europe Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2021e) & (Kiloton)
Table 109. Europe Alpha-Adrenoreceptor Antagonists Sales by Application (2021-2026) & (Kiloton)
Table 110. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Region (2016-2021e) & (Kiloton)
Table 111. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Region (2021-2026) & (Kiloton)
Table 112. Asia-Pacific Alpha-Adrenoreceptor Antagonists Revenue by Region (2016-2021e) & (USD Million)
Table 113. Asia-Pacific Alpha-Adrenoreceptor Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 114. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2021e) & (Kiloton)
Table 115. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Type (2021-2026) & (Kiloton)
Table 116. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2021e) & (Kiloton)
Table 117. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales by Application (2021-2026) & (Kiloton)
Table 118. South America Alpha-Adrenoreceptor Antagonists Sales by Country (2016-2021e) & (Kiloton)
Table 119. South America Alpha-Adrenoreceptor Antagonists Sales by Country (2021-2026) & (Kiloton)
Table 120. South America Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 121. South America Alpha-Adrenoreceptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 122. South America Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2021e) & (Kiloton)
Table 123. South America Alpha-Adrenoreceptor Antagonists Sales by Type (2021-2026) & (Kiloton)
Table 124. South America Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2021e) & (Kiloton)
Table 125. South America Alpha-Adrenoreceptor Antagonists Sales by Application (2021-2026) & (Kiloton)
Table 126. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Country (2016-2021e) & (Kiloton)
Table 127. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Country (2021-2026) & (Kiloton)
Table 128. Middle East & Africa Alpha-Adrenoreceptor Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 129. Middle East & Africa Alpha-Adrenoreceptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 130. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Type (2016-2021e) & (Kiloton)
Table 131. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Type (2021-2026) & (Kiloton)
Table 132. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Application (2016-2021e) & (Kiloton)
Table 133. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales by Application (2021-2026) & (Kiloton)
Table 134. Direct Channel Pros & Cons
Table 135. Indirect Channel Pros & Cons
Table 136. Alpha-Adrenoreceptor Antagonists Typical Distributors
Table 137. Alpha-Adrenoreceptor Antagonists Typical Customers
List of Figures
Figure 1. Alpha-Adrenoreceptor Antagonists Picture
Figure 2. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Alpha-Adrenoreceptor Antagonists Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 9. Global Alpha-Adrenoreceptor Antagonists Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Alpha-Adrenoreceptor Antagonists Sales (2016-2026) & (Kiloton)
Figure 11. Global Alpha-Adrenoreceptor Antagonists Price by Type (2016-2026) & (US$/Ton)
Figure 12. Global Alpha-Adrenoreceptor Antagonists Production Capacity (2016-2026) & (Kiloton)
Figure 13. Global Alpha-Adrenoreceptor Antagonists Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Alpha-Adrenoreceptor Antagonists Market Drivers
Figure 15. Alpha-Adrenoreceptor Antagonists Market Restraints
Figure 16. Alpha-Adrenoreceptor Antagonists Market Trends
Figure 17. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Manufacturer in 2020
Figure 18. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Manufacturer in 2020
Figure 19. Alpha-Adrenoreceptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Alpha-Adrenoreceptor Antagonists Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Alpha-Adrenoreceptor Antagonists Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Region (2016-2026)
Figure 23. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Region (2016-2026)
Figure 24. North America Alpha-Adrenoreceptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 25. Europe Alpha-Adrenoreceptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Alpha-Adrenoreceptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 27. South America Alpha-Adrenoreceptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Alpha-Adrenoreceptor Antagonists Revenue (2016-2026) & (USD Million)
Figure 29. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2016-2026)
Figure 30. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Type (2016-2026)
Figure 31. Global Alpha-Adrenoreceptor Antagonists Price by Type (2016-2026) & (US$/Ton)
Figure 32. Global Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2016-2026)
Figure 33. Global Alpha-Adrenoreceptor Antagonists Revenue Market Share by Application (2016-2026)
Figure 34. Global Alpha-Adrenoreceptor Antagonists Price by Application (2016-2026) & (US$/Ton)
Figure 35. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2016-2026)
Figure 36. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2016-2026)
Figure 37. North America Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2016-2026)
Figure 38. North America Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 39. United States Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2016-2026)
Figure 43. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2016-2026)
Figure 44. Europe Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2016-2026)
Figure 45. Europe Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 46. Germany Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Alpha-Adrenoreceptor Antagonists Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Alpha-Adrenoreceptor Antagonists Revenue Market Share by Region (2016-2026)
Figure 55. China Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2016-2026)
Figure 62. South America Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2016-2026)
Figure 63. South America Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2016-2026)
Figure 64. South America Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Alpha-Adrenoreceptor Antagonists Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Alpha-Adrenoreceptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Alpha-Adrenoreceptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のP2X7受容体拮抗薬市場 2021：企業別、地域別、種類・用途別 The P2X7 Receptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界のセロトニン拮抗薬市場 2021：企業別、地域別、種類・用途別 The Serotonin Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のカルシウム拮抗薬市場 2021：企業別、地域別、種類・用途別 The Calcium Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のアルファ-イオノン市場 2021：企業別、地域別、種類・用途別 The Alpha-Ionone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recen…
- 世界のアルファ-テルピネン市場 2021：企業別、地域別、種類・用途別 The alpha-Terpinene market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…